Orbustherapeutics
2 known investors
Orbus Therapeutics develops and commercializes therapies for patients with rare diseases that have few effective treatments, currently working on eflornithine in North America and Europe. Its lead program targets grade 3 astrocytoma, evaluated in the completed STELLAR clinical study.
BiotechHealthtech